These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 19559755)

  • 1. Epigenetic mechanisms in schizophrenia.
    Roth TL; Lubin FD; Sodhi M; Kleinman JE
    Biochim Biophys Acta; 2009 Sep; 1790(9):869-77. PubMed ID: 19559755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia.
    Dong E; Agis-Balboa RC; Simonini MV; Grayson DR; Costa E; Guidotti A
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12578-83. PubMed ID: 16113080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epigenetic model in the pharmacologic modulation of vulnerability to schizophrenia].
    Tremolizzo L
    Encephale; 2007 Nov; 33(Pt 3):867-9. PubMed ID: 18402359
    [No Abstract]   [Full Text] [Related]  

  • 4. GABAergic promoter hypermethylation as a model to study the neurochemistry of schizophrenia vulnerability.
    Costa E; Chen Y; Dong E; Grayson DR; Kundakovic M; Maloku E; Ruzicka W; Satta R; Veldic M; Zhubi A; Guidotti A
    Expert Rev Neurother; 2009 Jan; 9(1):87-98. PubMed ID: 19102671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of reelin and brain-derived neurotrophic factor genes in long-term potentiation in rat medial prefrontal cortex.
    Sui L; Wang Y; Ju LH; Chen M
    Neurobiol Learn Mem; 2012 May; 97(4):425-40. PubMed ID: 22469747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA (cytosine-5) methyltransferase inhibitors: a potential therapeutic agent for schizophrenia.
    Levenson JM
    Mol Pharmacol; 2007 Mar; 71(3):635-7. PubMed ID: 17179443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-occurrence of neurodevelopmental genes in etiopathogenesis of autism and schizophrenia.
    Fatemi SH
    Schizophr Res; 2010 May; 118(1-3):303-4. PubMed ID: 20153953
    [No Abstract]   [Full Text] [Related]  

  • 8. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability.
    Tremolizzo L; Carboni G; Ruzicka WB; Mitchell CP; Sugaya I; Tueting P; Sharma R; Grayson DR; Costa E; Guidotti A
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17095-100. PubMed ID: 12481028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients.
    Dong E; Ruzicka WB; Grayson DR; Guidotti A
    Schizophr Res; 2015 Sep; 167(1-3):35-41. PubMed ID: 25476119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia.
    Grayson DR; Chen Y; Costa E; Dong E; Guidotti A; Kundakovic M; Sharma RP
    Pharmacol Ther; 2006 Jul; 111(1):272-86. PubMed ID: 16574235
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Dong E; Locci V; Gatta E; Grayson DR; Guidotti A
    Mol Pharmacol; 2019 Jan; 95(1):62-69. PubMed ID: 30397000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic downregulation of GABAergic function in schizophrenia: potential for pharmacological intervention?
    Costa E; Grayson DR; Guidotti A
    Mol Interv; 2003 Jun; 3(4):220-9. PubMed ID: 14993449
    [No Abstract]   [Full Text] [Related]  

  • 13. Epigenetic aspects in schizophrenia etiology and pathogenesis.
    Popov NT; Stoyanova VK; Madzhirova NP; Vachev TI
    Folia Med (Plovdiv); 2012; 54(2):12-6. PubMed ID: 23101279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics.
    Sharma RP
    Schizophr Res; 2005 Jan; 72(2-3):79-90. PubMed ID: 15560954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes.
    Kundakovic M; Chen Y; Costa E; Grayson DR
    Mol Pharmacol; 2007 Mar; 71(3):644-53. PubMed ID: 17065238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes.
    Kundakovic M; Chen Y; Guidotti A; Grayson DR
    Mol Pharmacol; 2009 Feb; 75(2):342-54. PubMed ID: 19029285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation status of the reelin promoter region in the brain of schizophrenic patients.
    Tochigi M; Iwamoto K; Bundo M; Komori A; Sasaki T; Kato N; Kato T
    Biol Psychiatry; 2008 Mar; 63(5):530-3. PubMed ID: 17870056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of RELN and GAD1 in the frontal cortex (FC) of autism spectrum disorder (ASD) subjects.
    Zhubi A; Chen Y; Guidotti A; Grayson DR
    Int J Dev Neurosci; 2017 Nov; 62():63-72. PubMed ID: 28229923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic aberration of the human REELIN gene in psychiatric disorders.
    Tamura Y; Kunugi H; Ohashi J; Hohjoh H
    Mol Psychiatry; 2007 Jun; 12(6):519, 593-600. PubMed ID: 17310238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methylation of the Reelin Gene Promoter in Peripheral Blood and Its Relationship with the Cognitive Function of Schizophrenia Patients].
    Alfimova MV; Kondratiev NV; Golov AK; Golimbet VE
    Mol Biol (Mosk); 2018; 52(5):782-792. PubMed ID: 30363053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.